STERIS plc (STE)
Payables turnover
Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 3,056,750 | 2,902,220 | 2,555,540 | 2,568,700 | 1,764,420 |
Payables | US$ in thousands | 280,770 | 251,723 | 279,620 | 225,737 | 156,950 |
Payables turnover | 10.89 | 11.53 | 9.14 | 11.38 | 11.24 |
March 31, 2025 calculation
Payables turnover = Cost of revenue ÷ Payables
= $3,056,750K ÷ $280,770K
= 10.89
The payables turnover ratio for STERIS plc has shown variability over the years based on the available data. In March 2021, the payables turnover was 11.24 times, indicating that the company was able to convert its accounts payable into cash 11.24 times during the year. This ratio increased slightly to 11.38 times by March 2022, suggesting a slightly more efficient management of payables during that period.
However, there was a notable decrease in the payables turnover ratio to 9.14 times by March 2023, which may indicate a potential slowdown in the company's ability to convert its payables into cash efficiently. Subsequently, the ratio improved to 11.53 times by March 2024, indicating better management of payables during that year.
It is important to note that the payables turnover for March 2025 is not available in the data provided. This missing information limits the ability to provide a comprehensive analysis for that period. Overall, fluctuations in the payables turnover ratio can provide insights into STERIS plc's efficiency in managing its payables and potential cash flow implications.
Peer comparison
Mar 31, 2025